ACAD · Acadia Pharmaceuticals Inc

$28.24 -0.14 (-0.49%) At close · Aug 14

Market Cap

$4.87B

172.31M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Catherine Owen	—	$930,000	—	$3,240,558	$3,234,797	$818,559	$32,604	$8,256,518
Mark C	Schneyer	$546,428	—	$1,121,727	$1,119,738	$303,341	$28,174	$3,119,408
Jennifer J	Rhodes and Secretary	$538,783	—	$1,035,929	$1,034,091	$299,104	$19,990	$2,927,897
Elizabeth H.Z	Thompson and Development	$647,325	—	$925,611	$923,958	$372,272	$19,217	$2,888,383
Thomas Garner	Chief Commercial Officer	$525,000	—	—	—	$299,250	$32,773	$857,023

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stephen R	Davis	$648,599	—	$4,911,872	$3,516,219	—	$3,130,226	$12,206,915
Catherine Owen	—	$245,769	$196,721	$3,321,364	$3,316,803	—	$513,450	$7,594,107
Elizabeth H.Z	Thompson and Development	$281,884	—	$986,878	$2,860,444	$117,399	$15,339	$4,261,944
Thomas Garner	Chief Commercial Officer	$32,813	—	$851,179	$2,586,910	—	$200,049	$3,670,951
Jennifer J	Rhodes and Secretary	$478,026	—	$666,383	$1,912,975	$207,933	$2,031	$3,267,348
Mark C	Schneyer	$518,470	—	$881,810	$843,803	$226,719	$46,711	$2,517,513

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stephen R	Davis	$856,593	—	$1,948,017	$3,865,652	$886,184	$30,568	$7,587,014
Douglas J	Williamson Research and Development	$536,192	—	$960,925	$2,724,467	$347,178	$19,931	$4,588,693
Brendan P	Teehan Head of Commercial	$500,650	—	$592,883	$1,176,507	$323,716	$24,834	$2,618,590
Mark C	Schneyer	$484,842	—	$592,883	$1,176,507	$313,494	$23,478	$2,591,204
Austin D. Kim	President, General Counsel, and Secretary	$509,433	—	$395,241	$784,333	$329,395	$6,144	$2,024,546
Elizabeth H.Z	Thompson and Development	—	—	—	—	—	—	—
Catherine Owen	—	—	—	—	—	—	—	—
Thomas Garner	Chief Commercial Officer	—	—	—	—	—	—	—
Jennifer J	Rhodes and Secretary	—	—	—	—	—	—	—

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stephen R	Davis	$822,316	—	$8,926,598	$3,643,271	$615,810	$20,144	$14,028,139
Stephen Davis	—	$822,316	—	$8,926,598	$3,643,271	$615,810	$20,144	$14,028,139
Srdjan Stankovic	—	$755,103	—	$4,657,377	$1,900,838	$459,041	$25,268	$7,797,628
Austin D. Kim	President, General Counsel, and Secretary	$489,042	—	$2,924,370	$890,573	$228,895	$4,212	$4,537,092
Mark C	Schneyer	$467,283	—	$543,351	$1,108,825	$218,515	$15,230	$2,353,204
Mark Schneyer	Chief Financial Officer	$467,283	—	$543,351	$1,108,825	$218,515	$15,230	$2,353,204
Brendan Teehan	Chief Operating Officer and Head of Commercial	$482,521	—	$517,472	$1,056,028	$225,641	$16,148	$2,297,810
Brendan P	Teehan Head of Commercial	$482,521	—	$220,199	$222,643	$225,641	$16,148	$1,167,152
Jennifer J	Rhodes and Secretary	—	—	—	—	—	—	—
Douglas J	Williamson Research and Development	—	—	—	—	—	—	—
Elizabeth H.Z	Thompson and Development	—	—	—	—	—	—	—
Catherine Owen	—	—	—	—	—	—	—	—
Thomas Garner	Chief Commercial Officer	—	—	—	—	—	—	—

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stephen Davis	—	$792,831	—	$4,355,433	$4,403,433	$196,654	$44,937	$9,793,289
Stephen R	Davis	$792,831	—	$4,355,433	$4,403,433	$196,654	$44,937	$9,793,289
Srdjan Stankovic	—	$739,377	—	$1,957,468	$1,979,073	$149,008	$44,711	$4,869,637
Mark Schneyer	Chief Financial Officer	$398,183	—	$2,083,089	$544,236	$52,337	$104,973	$3,182,819
Mark C	Schneyer	$398,183	—	$2,083,089	$544,236	$52,337	$104,973	$3,182,819
Brendan P	Teehan Head of Commercial	$393,917	—	$1,765,002	$222,643	$48,065	$44,488	$2,474,115
Brendan Teehan	Chief Operating Officer and Head of Commercial	$393,917	—	$1,765,002	$222,643	$48,065	$44,488	$2,474,115
Elena Ridloff	Chief Financial Officer	$398,871	—	$978,784	$989,523	—	$22,096	$2,389,704
General Counsel	and Secretary	$470,180	—	$880,895	$890,573	$65,606	$23,449	$2,330,704
Austin D. Kim	President, General Counsel, and Secretary	$470,180	—	$880,895	$890,573	$65,606	$23,449	$2,330,704
Douglas J	Williamson Research and Development	—	—	—	—	—	—	—

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stephen Davis	—	$767,624	—	$3,262,978	$3,273,559	$438,601	$20,425	$7,763,187
Srdjan Stankovic	—	$715,869	—	$1,864,547	$1,870,608	$379,813	$25,577	$4,856,415
Michael Yang	Commercial Officer	$516,805	—	$932,316	$935,316	$210,921	$25,321	$2,620,679
Elena Ridloff	Chief Financial Officer	$462,000	—	$932,316	$935,316	$169,698	$14,840	$2,514,170
Austin D. Kim	—	$448,751	—	$559,355	$561,175	$164,832	$13,174	$1,747,288
General Counsel	and Secretary	$448,751	—	$559,355	$561,175	$164,832	$13,174	$1,747,288

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stephen Davis	—	$743,705	—	$3,140,000	$3,127,738	$597,485	$22,318	$7,631,245
Srdjan Stankovic	—	$693,563	—	$1,932,331	$1,924,767	$517,401	$20,208	$5,088,270
Michael Yang	Commercial Officer	$500,701	—	$1,291,323	$842,087	$287,328	$22,383	$2,943,821
Elena Ridloff	Chief Financial Officer	$444,026	—	$652,165	$649,614	$229,324	$15,737	$1,990,867
General Counsel	and Secretary	$435,913	—	$603,835	$601,492	$225,134	$39,753	$1,906,126

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Stephen Davis	—	$719,833	—	$505,400	$4,771,631	$493,806	$17,362	$6,508,032
Srdjan Stankovic	—	$524,785	—	$705,700	$4,094,313	$334,289	$19,294	$5,678,381
Michael Yang	Commercial Officer	$485,250	—	$212,800	$2,077,607	$237,773	$169,480	$3,182,910
General Counsel	and Secretary	$195,704	$200,000	—	$1,597,106	$86,306	$47,096	$2,126,212

Executive changes

Person	Role	Change	Effective	Filed
Jonathan M. Poole	Class II director	Appointed	2026-03-03	2026-03-05
Daniel B. Soland	member of the Board	Resigned	2025-10-30	2025-11-03
Brendan Teehan	Executive Vice President, Chief Operating Officer and Head of Commercial	Terminated	2024-11-18	2024-11-20
Catherine Owen Adams	Class III director	Appointed	2024-09-23	2024-09-23
Stephen R. Davis	member of the Board	Resigned	2024-09-23	2024-09-23
Catherine Owen Adams	Chief Executive Officer	Appointed	2024-09-23	2024-09-23
Stephen R. Davis	President and Chief Executive Officer	Terminated	2024-09-23	2024-09-23
Daniel B. Soland	Class II director	Appointed	2024-05-29	2024-05-29
Stephen R. Biggar, M.D., Ph.D.	Class II director	Appointed	2024-05-29	2024-05-29
Julian C. Baker	Class II director	Appointed	2024-05-29	2024-05-29
Srdjan R. Stankovic, M.D., M.S.P.H.	President	Retired	2022-12-31	2022-10-28
Adora Ndu, Pharm.D., J.D.	director	Appointed	2022-10-12	2022-10-13

Key facts CIK 1070494 CUSIP 004225108 13F (30d) 351 filings 323 filers Visit website Investor relations